GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Cardlytics Inc (NAS:CDLX) » Definitions » Cash, Cash Equivalents, Marketable Securities

Cardlytics (Cardlytics) Cash, Cash Equivalents, Marketable Securities : $97.8 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cardlytics Cash, Cash Equivalents, Marketable Securities?

Cardlytics's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 ($90.07 Mil) to Dec. 2023 ($91.83 Mil) and increased from Dec. 2023 ($91.83 Mil) to Mar. 2024 ($97.77 Mil).

Cardlytics's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($233.47 Mil) to Dec. 2022 ($121.91 Mil) and declined from Dec. 2022 ($121.91 Mil) to Dec. 2023 ($91.83 Mil).


Cardlytics Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Cardlytics's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardlytics Cash, Cash Equivalents, Marketable Securities Chart

Cardlytics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only 104.46 293.24 233.47 121.91 91.83

Cardlytics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.19 92.07 90.07 91.83 97.77

Cardlytics Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Cardlytics  (NAS:CDLX) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Cardlytics Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cardlytics's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardlytics (Cardlytics) Business Description

Industry
Traded in Other Exchanges
Address
675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, GA, USA, 30308
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Executives
Clifford Sosin 10 percent owner 8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880
Karim Saad Temsamani director, officer: Chief Executive Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Nicholas Hollmeyer Lynton officer: Chief Legal & Privacy Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Alex Mishurov director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308
Scott A Hill director INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328
Alexis Desieno officer: Chief Financial Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Andrew Christiansen officer: Chief Financial Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Chris Suh director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308
Jessica Jensen director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Amit Gupta officer: Chief Operating Officer C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
John V Balen director
Scott D. Grimes director, officer: Chief Executive Officer CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Lynne Marie Laube director, officer: Chief Operating Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Kirk Somers officer: Chief Legal & Privacy Officer
S Aimee Lapic director 2101 WEBSTER ST #1650, OAKLAND CA 94612